Global Sphingosine 1-Phosphate Receptor 1 Market Size, Share, Trends and Forecast 2022-2030

Description

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Industry Insights

Due to the COVID-19 pandemic, the global Sphingosine 1-Phosphate Receptor 1 market size is estimated to be worth US$ 3388.3 million in 2021 and is forecast to a readjusted size of US$ 5998.4 million by 2028 with a CAGR of 8.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Sphingosine 1-Phosphate Receptor 1 market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Sphingosine 1-Phosphate Receptor 1 landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.

This report focuses on Sphingosine 1-Phosphate Receptor 1 volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Sphingosine 1-Phosphate Receptor 1 market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, South America, Africa and Middle East, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Sphingosine 1-Phosphate Receptor 1 market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Fingolimod

Siponimod

Ozanimod

Other

Segment by Application

Hospital

Clinic

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Novartis AG

Bristol-Myers Squibb Company

TABLE OF CONTENT

1 Sphingosine 1-Phosphate Receptor 1 Market Overview
1.1 Product Overview and Scope of Sphingosine 1-Phosphate Receptor 1

1.2 Sphingosine 1-Phosphate Receptor 1 Segment by Type

1.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Fingolimod

1.2.3 Siponimod

1.2.4 Ozanimod

1.2.5 Other

1.3 Sphingosine 1-Phosphate Receptor 1 Segment by Application

1.3.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Comparison by Application: (2022-2028)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Sphingosine 1-Phosphate Receptor 1 Market Size Estimates and Forecasts

1.4.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue 2017-2028

1.4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales 2017-2028

1.4.3 Sphingosine 1-Phosphate Receptor 1 Market Size by Region: 2017 Versus 2021 Versus 2028

2 Sphingosine 1-Phosphate Receptor 1 Market Competition by Manufacturers

2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Manufacturers (2017-2022)

2.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Sphingosine 1-Phosphate Receptor 1 Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Sphingosine 1-Phosphate Receptor 1 Manufacturing Sites, Area Served, Product Type

2.5 Sphingosine 1-Phosphate Receptor 1 Market Competitive Situation and Trends

2.5.1 Sphingosine 1-Phosphate Receptor 1 Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Sphingosine 1-Phosphate Receptor 1 Players Market Share by Revenue

2.5.3 Global Sphingosine 1-Phosphate Receptor 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sphingosine 1-Phosphate Receptor 1 Retrospective Market Scenario by Region

3.1 Global Sphingosine 1-Phosphate Receptor 1 Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Sphingosine 1-Phosphate Receptor 1 Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country

3.3.1 North America Sphingosine 1-Phosphate Receptor 1 Sales by Country

3.3.2 North America Sphingosine 1-Phosphate Receptor 1 Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country

3.4.1 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country

3.4.2 Europe Sphingosine 1-Phosphate Receptor 1 Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Region

3.5.1 Asia Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Region

3.5.2 Asia Pacific Sphingosine 1-Phosphate Receptor 1 Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country

3.6.1 Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Country

3.6.2 Latin America Sphingosine 1-Phosphate Receptor 1 Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country

3.7.1 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country

3.7.2 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Sphingosine 1-Phosphate Receptor 1 Historic Market Analysis by Type

4.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2022)

4.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Type (2017-2022)

4.3 Global Sphingosine 1-Phosphate Receptor 1 Price by Type (2017-2022)

5 Global Sphingosine 1-Phosphate Receptor 1 Historic Market Analysis by Application

5.1 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2022)

5.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Application (2017-2022)

5.3 Global Sphingosine 1-Phosphate Receptor 1 Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Novartis AG

6.1.1 Novartis AG Corporation Information

6.1.2 Novartis AG Description and Business Overview

6.1.3 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Novartis AG Sphingosine 1-Phosphate Receptor 1 Product Portfolio

6.1.5 Novartis AG Recent Developments/Updates

6.2 Bristol-Myers Squibb Company

6.2.1 Bristol-Myers Squibb Company Corporation Information

6.2.2 Bristol-Myers Squibb Company Description and Business Overview

6.2.3 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product Portfolio

6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates

7 Sphingosine 1-Phosphate Receptor 1 Manufacturing Cost Analysis

7.1 Sphingosine 1-Phosphate Receptor 1 Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Sphingosine 1-Phosphate Receptor 1

7.4 Sphingosine 1-Phosphate Receptor 1 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Sphingosine 1-Phosphate Receptor 1 Distributors List

8.3 Sphingosine 1-Phosphate Receptor 1 Customers

9 Sphingosine 1-Phosphate Receptor 1 Market Dynamics

9.1 Sphingosine 1-Phosphate Receptor 1 Industry Trends

9.2 Sphingosine 1-Phosphate Receptor 1 Market Drivers

9.3 Sphingosine 1-Phosphate Receptor 1 Market Challenges

9.4 Sphingosine 1-Phosphate Receptor 1 Market Restraints

10 Global Market Forecast

10.1 Sphingosine 1-Phosphate Receptor 1 Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Sphingosine 1-Phosphate Receptor 1 by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Sphingosine 1-Phosphate Receptor 1 by Type (2023-2028)

10.2 Sphingosine 1-Phosphate Receptor 1 Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Sphingosine 1-Phosphate Receptor 1 by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Sphingosine 1-Phosphate Receptor 1 by Application (2023-2028)

10.3 Sphingosine 1-Phosphate Receptor 1 Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Sphingosine 1-Phosphate Receptor 1 by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Sphingosine 1-Phosphate Receptor 1 by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample